Springer Nature
Browse
40880_2019_405_MOESM1_ESM.docx (17.49 kB)

MOESM1 of Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study

Download (17.49 kB)
journal contribution
posted on 2019-10-24, 13:55 authored by Wen Cai, Biao Cai, Juan Zhou, Yonghui Chen, Jin Zhang, Yiran Huang, Wei Xue, Jiwei Huang
Additional file 1. Patients and methods.

Funding

Shanghai Science and Technology Commission

History

Usage metrics

    Chinese Journal of Cancer

    Categories

    Keywords

    sunitinibcell carcinoma1. Patientsretrospective studyneoadjuvant therapysafetymethodMOESM 1efficacyaxitinibsorafenib

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC